Patent details

EP4157272 Title: REMDESIVIR FOR THE TREATMENT OF VIRAL INFECTIONS

Basic Information

Publication number:
EP4157272
PCT Application Number:
US2021034764
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP217333483
PCT Publication Number:
WO2021243157
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REMDESIVIR FOR THE TREATMENT OF VIRAL INFECTIONS
French Title of Invention:
REMDÉSIVIR POUR LE TRAITEMENT DES INFECTIONS VIRALES
German Title of Invention:
REMDESIVIR ZUR BEHANDLUNG VON VIRALEN INFEKTIONEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
31/07/2025
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
11/08/2025
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
02/07/2025
Unitary Effect Registration Date:
11/08/2025
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
28/05/2021
Grant date:
02/07/2025
EP Publication Date:
05/04/2023
PCT Publication Date:
02/12/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/07/2025
EP B1 Publication Date:
02/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
28/05/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/06/2025
 
 

Name:
GILEAD SCIENCES, INC.
Address:
333 Lakeside Drive, Foster City, California 94404, United States (US)

Inventor

Name:
CIHLAR, Tomas
Address:
United States (US)

Priority

Priority Number:
202063032321 P
Priority Date:
29/05/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4706; A61K 31/706; A61P 31/14;

Publication

European Patent Bulletin

1

Issue number:
202527
Publication date:
02/07/2025
Description:
Grant (B1)

2

Issue number:
202531
Publication date:
30/07/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202536
Publication date:
03/09/2025
Description:
Unitary Effect Request Receipt

4

Issue number:
202537
Publication date:
10/09/2025
Description:
Unitary Effect Request Acceptance

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages